Log In
person
FibroGen Inc
FGEN
summarize
4 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Pharma for Diversified Diseases |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
100.95M | 68.32% |
| Pharma for Diversified Diseases |
Active Pharma Ingredients
These companies develop and manufacture Active Pharmaceutical Ingredients (APIs) that are used to create finished drugs.
|
18.75M | 12.69% |
| Pharma for Diversified Diseases |
Contract Research for Drug Manufacturers
These companies do contract services for biotech and pharmaceutical companies.
|
18.4M | 12.45% |
| Pharma for Diversified Diseases |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
9.65M | 6.53% |
| keyboard_arrow_down |
Pharma for Diversified Diseases
Branded Pharmaceuticals (outsourced)
|
100.95M | 68.32% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Pharma for Diversified Diseases
Active Pharma Ingredients
|
18.75M | 12.69% |
| keyboard_arrow_right |
These companies develop and manufacture Active Pharmaceutical Ingredients (APIs) that are used to create finished drugs.
|
||
| keyboard_arrow_down |
Pharma for Diversified Diseases
Contract Research for Drug Manufacturers
|
18.4M | 12.45% |
| keyboard_arrow_right |
These companies do contract services for biotech and pharmaceutical companies.
|
||
| keyboard_arrow_down |
Pharma for Diversified Diseases
Pharmaceutical Patent Licensing
|
9.65M | 6.53% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||